• | home
  • | corporate
  • | investors
  • | products
  • | clinical trials
  • | partnering
  • | contact
TSX: HBP - NYSE Amex: HBP - Frankfurt: HBP

Regulatory Filings
  • | Overview
  • | Corporate Governance
    • | Board Mandate
    • | Board Committee Charters
    • | Whistleblowing Policy
    • | Code of Conduct
  • | Investor Fact Sheet
  • | News Releases
    • | Fiscal 2012
    • | Archive
  • | Financial Statements
    • | Fiscal 2012
    • | Archive
  • | Annual Reports
  • | Regulatory Filings
  • | Analyst Coverage
  • | Presentations
    • | Corporate Presentations
    • | Scientific Presentations
  • | FAQ Investor Relations
  • | Stock Quote
  • | Shareholder Services
  • | Email Alerts
  • | Legal Disclaimer
  • | Contact IR

Regulatory Filings

Helix’s regulatory filings can be found on www.sedar.com and on www.sec.gov.

January 23, 2012 LETTER TO SHAREHOLDERS IN CONNECTION WITH THE JANUARY 2012 ANNUAL GENERAL MEETING
OF SHAREHOLDERS
January 6, 2012 Notice and Management Proxy Circular For The January 2012 Annual General Meeting of Shareholders
January 6, 2012 Form of Proxy
January 6, 2012 Voting Instruction Form ("VIF")
   
   
   
   
   
   
   
   
   
   

 



  • | home
  • | site map
  • | privacy
  • | terms of use / disclaimers
  • | polski
  • | login
© Helix BioPharma Corp.